DEVICE · Unmapped registry intervention
TNM Device
Find medicine records ·
Find other trials using this name
Clinical trial
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
NCT02130401
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedExamining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
TNM DeviceDEVICE
Sponsors & collaborators
Scion NeuroStimlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02130401 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.